A citation-based method for searching scientific literature

Josep Tabernero, Paulo M Hoff, Lin Shen, Atsushi Ohtsu, Manish A Shah, Karen Cheng, Chunyan Song, Haiyan Wu, Jennifer Eng-Wong, Katherine Kim, Yoon-Koo Kang. Lancet Oncol 2018
Times Cited: 195



Charles S Fuchs, Kohei Shitara, Maria Di Bartolomeo, Sara Lonardi, Salah-Eddin Al-Batran, Eric Van Cutsem, David H Ilson, Maria Alsina, Ian Chau, Jill Lacy, Michel Ducreux, Guillermo Ariel Mendez, Alejandro Molina Alavez, Daisuke Takahari, Wasat Mansoor, Peter C Enzinger, Vera Gorbounova, Zev A Wainberg, Susanna Hegewisch-Becker, David Ferry, Ji Lin, Roberto Carlesi, Mayukh Das, Manish A Shah. Lancet Oncol 2019
Times Cited: 110




List of shared articles



Times cited

Efficacy and safety of targeted drugs in advanced or metastatic gastric and gastroesophageal junction cancer: A network meta-analysis.
Hongxia Gong, Yun Su, Lixia Zhao, Li Ma, Liying Zhang, Liangying Hou, Tingting Li, Shiwei Niu, Han Zhang, Chenghao Li,[...]. J Clin Pharm Ther 2022
0

The dawn of precision medicine in diffuse-type gastric cancer.
Akira Ooki, Kensei Yamaguchi. Ther Adv Med Oncol 2022
2

Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.
Aracelis Z Torres, Nathan C Nussbaum, Christina M Parrinello, Ariel B Bourla, Bryan E Bowser, Samuel Wagner, David C Tabano, Daniel George, Rebecca A Miksad. Adv Ther 2022
0

Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
Daniel V T Catenacci, Stephanie Moya, Samantha Lomnicki, Leah M Chase, Bryan F Peterson, Natalie Reizine, Lindsay Alpert, Namrata Setia, Shu-Yuan Xiao, John Hart,[...]. Cancer Discov 2021
22

Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies.
Salma K Jabbour, Terence M Williams, Mutlay Sayan, Eric D Miller, Jaffer A Ajani, Andrew C Chang, Norman Coleman, Wael El-Rifai, Michael Haddock, David Ilson,[...]. J Natl Cancer Inst 2021
1

Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Felipe Alvarez-Manceñido, Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Virginia Arrazubi, Raquel Hernandez, Juana M Cano, Ana Custodio, Carles Pericay Pijaume, Gema Aguado, Nieves Martínez Lago,[...]. Gastric Cancer 2021
1

Changes in the therapeutic landscape of oesophago-gastric cancers.
Nina Fokter Dovnik, Elizabeth C Smyth. Curr Opin Oncol 2021
0

Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them.
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, Davide Bosso, Laura Attademo, Cinzia Cardalesi, Anna Diana, Antonietta Fabbrocini, Teresa Fabozzi, Pasqualina Giordano,[...]. J Clin Med 2021
4

Evolving treatment paradigms in esophageal cancer.
Ilit Turgeman, Irit Ben-Aharon. Ann Transl Med 2021
6

Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Daniel V Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J Klempner, Zev A Wainberg, Manish A Shah, Sun Young Rha, Atsushi Ohtsu, Astra M Liepa,[...]. Oncologist 2021
2